These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 231730)

  • 1. Reactivity of Paul-Bunnell type heterophile antibody in sera from infectious mononucleosis patients with the surface of lymphoid cells carrying Epstein-Barr virus genomes.
    Maeda M; Sairenji T; Hinuma Y
    Microbiol Immunol; 1979; 23(12):1189-97. PubMed ID: 231730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A modified immunofluorescence test for Epstein-Barr virus-specific IgM antibody.
    Harnett GB; Palmer CA; Bucens MR
    J Virol Methods; 1985 Oct; 12(1-2):25-30. PubMed ID: 3001120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cytotoxic effector cells from infectious mononucleosis patients in the acute phase do not specifically kill Epstein-Barr virus genome-carrying lymphoid cell lines.
    Patel PC; Dorval G; Menezes J
    Infect Immun; 1982 Oct; 38(1):251-9. PubMed ID: 6292093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A prospective evaluation of heterophile and Epstein-Barr virus-specific IgM antibody tests in clinical and subclinical infectious mononucleosis: Specificity and sensitivity of the tests and persistence of antibody.
    Evans AS; Niederman JC; Cenabre LC; West B; Richards VA
    J Infect Dis; 1975 Nov; 132(5):546-54. PubMed ID: 171321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IgM antibodies to Epstein-Barr virus-associated membrane antigen in sera of infectious mononucleosis patients.
    Harada M; Sairenji T; Takaki K; Hinuma Y
    Microbiol Immunol; 1980; 24(2):123-32. PubMed ID: 6247623
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infectious mononucleosis fifty years after the discovery of the Paul-Bunnell test.
    Burgio GR; Monafo V
    Infection; 1983; 11(1):1-5. PubMed ID: 6302006
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of tests for heterophile antibodies with a test for specific IgM-antibodies to Epstein-Barr virus. Brief report.
    Myrmel H
    APMIS; 1988 Mar; 96(3):280-1. PubMed ID: 2831918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterophile IgM, IgA, and IgE antibodies in infectious mononucleosis.
    Duverlie G; Driencourt M; Roussel C; Orfila J
    J Med Virol; 1989 May; 28(1):38-41. PubMed ID: 2542444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
    Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
    Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary versus reactivated Epstein-Barr virus infection in patients with VCA IgG-, VCA IgM- and EBNA-1-antibodies and suspected infectious mononucleosis.
    Nystad TW; Myrmel H
    J Clin Virol; 2007 Apr; 38(4):292-7. PubMed ID: 17336144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epstein-Barr virus. Heterophile responses in squirrel monkeys inoculated with virus-transformed autologous leukocytes.
    Shope T; Miller G
    J Exp Med; 1973 Jan; 137(1):140-7. PubMed ID: 4347289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterophil antigen in bovine sera detectable by immune adherence hemagglutination with infectious mononucleosis sera.
    Lennette ET; Henle G; Henle W; Horwitz CA
    Infect Immun; 1978 Mar; 19(3):923-7. PubMed ID: 205510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody response to Epstein-Barr virus in infectious mononucleosis.
    Nikoskelainen J; Hänninen P
    Infect Immun; 1975 Jan; 11(1):42-51. PubMed ID: 163790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limitations of immunofluorescence tests in the diagnosis of infectious mononucleosis.
    Joncas JH; Gilker JC; Chagnon A
    Can Med Assoc J; 1974 Apr; 110(7):793-4 passim. PubMed ID: 4363398
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of a surface antigen on Epstein-Barr virus genome-carrying lymphoid cells: distinction from the virus-determined membrane antigen.
    Sakamoto K; Hinuma Y
    J Immunol; 1978 May; 120(5):1702-8. PubMed ID: 207776
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epstein-Barr virus (EBV) antigen-specific leukocyte migration inhibition (LMI) in infectious mononucleosis (IM). I. Kinetics and response to a membrane protein on EBV-transformed cells.
    Szigeti R; Timar L; Weiland O; Henle W; Henle G; Hennessy K; Kieff E; Sulitzeanu D; Dillner J; Klein G
    Clin Immunol Immunopathol; 1986 Dec; 41(3):342-50. PubMed ID: 3022972
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Heterophile antibody positive infectious mononucleosis.
    Mishra B; Mohan B; Ratho RK
    Indian J Pediatr; 2004 Jan; 71(1):15-8. PubMed ID: 14979379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MLC response of patients with infectious mononucleosis to Epstein-Barr virus-transformed cells.
    Wasik M; Myc A; Matej H; Rudzka L
    Arch Immunol Ther Exp (Warsz); 1983; 31(6):871-8. PubMed ID: 6331340
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epstein-Barr virus infections in childhood.
    Oberender H; Graessner U; Falkenhagen U; Kunkel M; Gärtner L; Kupatz H; Schumacher K
    Acta Virol; 1979 Mar; 23(2):137-42. PubMed ID: 39436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of heterophile Paul-Bunnell antigen on human lymphoid cell lines.
    Sugisaki T; Kano K; Minowada J; Milgrom F
    Clin Immunol Immunopathol; 1981 Oct; 21(1):77-82. PubMed ID: 6974076
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.